FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Fosinopril Sodium And Hydrochlorothiazide patents expire, and when can generic versions of Fosinopril Sodium And Hydrochlorothiazide launch?
Fosinopril Sodium And Hydrochlorothiazide is a drug marketed by Ani Pharms, Aurobindo Pharma, Avet Lifesciences, Invagen Pharms, Mylan, Sandoz, Sun Pharm Inds Ltd, and Teva. and is included in nine NDAs.
The generic ingredient in FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE is fosinopril sodium; hydrochlorothiazide. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the fosinopril sodium; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fosinopril Sodium And Hydrochlorothiazide
A generic version of FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE was approved as fosinopril sodium; hydrochlorothiazide by SANDOZ on September 28th, 2005.
Summary for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 2 |
| Clinical Trials: | 2 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ranbaxy Laboratories Limited | N/A |
See all FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE clinical trials
Pharmacology for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
| Drug Class | Angiotensin Converting Enzyme Inhibitor Thiazide Diuretic |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Increased Diuresis |
Anatomical Therapeutic Chemical (ATC) Classes for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
US Patents and Regulatory Information for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | fosinopril sodium; hydrochlorothiazide | TABLET;ORAL | 076608-001 | Dec 3, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Teva | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | fosinopril sodium; hydrochlorothiazide | TABLET;ORAL | 076945-002 | Jul 5, 2006 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Avet Lifesciences | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | fosinopril sodium; hydrochlorothiazide | TABLET;ORAL | 079025-001 | Sep 17, 2010 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
